• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何提高医药行业研究成果的转化成功率?技术转移主体的博弈论模型。

How Can We Improve the Transformation Success Rate of Research Results in the Pharmaceutical Industry? The Game Theoretic Model of Technology Transfer Subjects.

机构信息

School of Management, China University of Mining and Technology, Xuzhou 221116, China.

出版信息

Int J Environ Res Public Health. 2019 May 7;16(9):1588. doi: 10.3390/ijerph16091588.

DOI:10.3390/ijerph16091588
PMID:31067650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6539642/
Abstract

University-industry technology transfer (UITT) plays an important role in the construction of the national pharmaceutical innovation system. The speculations of a faculty inventor may hinder the successful transfer of pharmaceutical research results. This paper divides the specific process of the transformation of pharmaceutical research results into two parts: (1) an evolutionary game between faculty inventors and universities; and (2) a Stackelberg game between faculty inventors and pharmaceutical companies. Further, we carry out numerical simulations to analyze the impact of transformation success rate, income distribution coefficient, and a faculty inventor's future working years on the transformation of pharmaceutical research results. The findings indicated that whether a combination of action strategies of faculty inventors and universities can evolve to the optimal equilibrium is determined by many factors, such as the technological transaction price of the pharmaceutical company and the reward or the income obtained by the faculty inventor. The transformation success rate and the income distribution coefficient are the key factors that affect the faculty inventor's will and the behavior of the pharmaceutical company. The conclusions of this paper contribute to the research on how we can improve the success rate of research results and avoid resource waste, and provide a decision-making reference for the management of pharmaceutical research results in universities.

摘要

产学研技术转移(UITT)在国家医药创新体系建设中发挥着重要作用。高校教师发明家的猜测可能会阻碍医药研究成果的成功转化。本文将医药研究成果转化的具体过程划分为两个部分:(1)高校教师与高校之间的演化博弈;(2)高校教师与医药企业之间的斯塔克伯格博弈。进一步通过数值模拟分析了转化成功率、收益分配系数以及高校教师未来工作年限对医药研究成果转化的影响。研究结果表明,高校教师与高校的组合行动策略是否能够演化到最优均衡,取决于医药公司的技术交易价格、高校教师的奖励或收入等诸多因素。转化成功率和收益分配系数是影响高校教师意愿和医药公司行为的关键因素。本文的结论有助于研究如何提高研究成果的成功率,避免资源浪费,并为高校医药研究成果管理提供决策参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a554739d17e6/ijerph-16-01588-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/ad3537dc1b91/ijerph-16-01588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a2870a3173ed/ijerph-16-01588-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/726ba561bc91/ijerph-16-01588-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/931c403addf7/ijerph-16-01588-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/076d5e90414d/ijerph-16-01588-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a0375777f846/ijerph-16-01588-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/09e3722cb495/ijerph-16-01588-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/033870556fd5/ijerph-16-01588-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/4b43cb5348af/ijerph-16-01588-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/62ed3720612b/ijerph-16-01588-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a766f3857d94/ijerph-16-01588-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/6fa02d3558af/ijerph-16-01588-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/455b0f092e24/ijerph-16-01588-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/82f0dcbfb909/ijerph-16-01588-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/0e173fbcce54/ijerph-16-01588-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/6fa8d7cdd87f/ijerph-16-01588-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/967bc1a5e5e3/ijerph-16-01588-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a554739d17e6/ijerph-16-01588-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/ad3537dc1b91/ijerph-16-01588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a2870a3173ed/ijerph-16-01588-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/726ba561bc91/ijerph-16-01588-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/931c403addf7/ijerph-16-01588-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/076d5e90414d/ijerph-16-01588-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a0375777f846/ijerph-16-01588-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/09e3722cb495/ijerph-16-01588-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/033870556fd5/ijerph-16-01588-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/4b43cb5348af/ijerph-16-01588-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/62ed3720612b/ijerph-16-01588-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a766f3857d94/ijerph-16-01588-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/6fa02d3558af/ijerph-16-01588-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/455b0f092e24/ijerph-16-01588-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/82f0dcbfb909/ijerph-16-01588-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/0e173fbcce54/ijerph-16-01588-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/6fa8d7cdd87f/ijerph-16-01588-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/967bc1a5e5e3/ijerph-16-01588-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fa/6539642/a554739d17e6/ijerph-16-01588-g018.jpg

相似文献

1
How Can We Improve the Transformation Success Rate of Research Results in the Pharmaceutical Industry? The Game Theoretic Model of Technology Transfer Subjects.如何提高医药行业研究成果的转化成功率?技术转移主体的博弈论模型。
Int J Environ Res Public Health. 2019 May 7;16(9):1588. doi: 10.3390/ijerph16091588.
2
Medical technology transfer: the inventor's perspective.医学技术转让:发明者的视角
Biomed Instrum Technol. 1991 Jan-Feb;25(1):35-41.
3
Collaborative university-industry R&D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review.协同式产学研发实践对药物创新过程的支持:基于文献计量学的研究。
Drug Discov Today. 2022 Aug;27(8):2333-2341. doi: 10.1016/j.drudis.2022.05.001. Epub 2022 May 10.
4
On Conflicts between Pharmaceutical Patent Protection and the Right to Life and Health Based on a Stackelberg Game.基于 Stackelberg 博弈的药品专利保护与生命健康权冲突研究
Int J Environ Res Public Health. 2021 Jan 27;18(3):1119. doi: 10.3390/ijerph18031119.
5
Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.连续制药生产中的控制系统工程。2014年5月20 - 21日,连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):832-9. doi: 10.1002/jps.24311. Epub 2014 Dec 26.
6
Industry-university collaborations: a necessity for the future.产学研合作:未来之必需。
J Dent. 1996 Jan-Mar;24(1-2):3-5. doi: 10.1016/0300-5712(95)00005-4.
7
A tripartite evolutionary game study on green governance in China's coating industry.中国涂料行业绿色治理的三方演化博弈研究
Environ Sci Pollut Res Int. 2022 Aug;29(40):61161-61177. doi: 10.1007/s11356-022-20220-2. Epub 2022 Apr 19.
8
A three evolutionary game model for driving mechanism of industry-university-research collaborative innovation in agricultural innovation ecosystems.农业创新生态系统中产学研协同创新的驱动机制的三阶段演化博弈模型。
PLoS One. 2023 Aug 3;18(8):e0289408. doi: 10.1371/journal.pone.0289408. eCollection 2023.
9
Academic-industrial relationships: opportunities and pitfalls.学术-产业关系:机遇与陷阱。
Sci Eng Ethics. 2002 Jul;8(3):443-54. doi: 10.1007/s11948-002-0066-6.
10
Fisheries management as a Stackelberg Evolutionary Game: Finding an evolutionarily enlightened strategy.渔业管理的斯塔克尔伯格进化博弈:寻找一种进化上明智的策略。
PLoS One. 2021 Jan 20;16(1):e0245255. doi: 10.1371/journal.pone.0245255. eCollection 2021.

引用本文的文献

1
Multivariate Pharma Technology Transfer Analysis: Civilization Diseases and COVID-19 Perspective.多变量制药技术转让分析:文明病与 COVID-19 的视角。
Int J Environ Res Public Health. 2023 Jan 20;20(3):1954. doi: 10.3390/ijerph20031954.

本文引用的文献

1
How Does CEO's Environmental Awareness Affect Technological Innovation?CEO 的环境意识如何影响技术创新?
Int J Environ Res Public Health. 2019 Jan 17;16(2):261. doi: 10.3390/ijerph16020261.
2
Enabling health technology innovation in Canada: Barriers and facilitators in policy and regulatory processes.加拿大医疗技术创新的推动因素:政策和监管流程中的障碍与促进因素。
Health Policy. 2019 Feb;123(2):203-214. doi: 10.1016/j.healthpol.2018.09.018. Epub 2018 Oct 12.
3
Can lifecycle management safeguard innovation in the pharmaceutical industry?
生命周期管理能否保障制药行业的创新?
Drug Discov Today. 2018 Dec;23(12):1962-1973. doi: 10.1016/j.drudis.2018.10.008. Epub 2018 Oct 17.
4
Technology Transfer: From the Research Bench to Commercialization: Part 1: Intellectual Property Rights-Basics of Patents and Copyrights.技术转移:从研究台到商业化:第1部分:知识产权——专利与版权基础
JACC Basic Transl Sci. 2017 Feb 27;2(1):85-97. doi: 10.1016/j.jacbts.2017.01.003. eCollection 2017 Feb.
5
Synergy between intention recognition and commitments in cooperation dilemmas.合作困境中意图识别与承诺之间的协同作用。
Sci Rep. 2015 Mar 20;5:9312. doi: 10.1038/srep09312.
6
New Zealand's drug development industry.新西兰的药品研发产业。
Int J Environ Res Public Health. 2013 Sep 13;10(9):4339-51. doi: 10.3390/ijerph10094339.
7
Good agreements make good friends.好的协议成就好朋友。
Sci Rep. 2013;3:2695. doi: 10.1038/srep02695.
8
Emergence of responsible sanctions without second order free riders, antisocial punishment or spite.负责任的制裁的出现,没有二阶免费搭车者、反社会惩罚或恶意。
Sci Rep. 2012;2:458. doi: 10.1038/srep00458. Epub 2012 Jun 13.
9
Reward, punishment, and cooperation: a meta-analysis.奖励、惩罚与合作:一项元分析。
Psychol Bull. 2011 Jul;137(4):594-615. doi: 10.1037/a0023489.
10
Process R&D under the magnifying glass: organization, business model, challenges, and scientific context.工艺研发的放大镜下:组织、商业模式、挑战和科学背景。
Bioorg Med Chem. 2010 Aug 15;18(16):5775-94. doi: 10.1016/j.bmc.2010.06.029. Epub 2010 Jun 16.